L'Oreal contributes to an important step towards validating alternative method in China

The experts from the multicenter study management group highly appraised that this multicenter study based on L’Oreal Chinese Episkin represents the very first validation of standardized and normative animal testing alternative methods in accordance with international standards in China, and this project provides a solid technical support for corresponding to the new regulation in European Union. It created a novel mode for making accordance with the international technical platform of animal testing alternative methods. More than thirty years of research on skin reconstruction and development of predictive methods have been recognized in this day and it is a great step towards the promotion of alternative methods in China by sharing knowledge and tools. This method has already allowed L’Oréal to comply with EU regulation without impact on sustainable innovation and safety and it won’t have any bad influence on L’Oreal expansion on Chinese market.  ( L’Oreal, 2013)

Reference

L’Oreal (2013) ‘L'Oreal contributes to an important step towards validating alternative method in China’, 14 November, Available at: http://www.loreal-finance.com/eng/news/research-innovation-926.htm (Accessed: 9 February, 2014)